Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
19.11
+1.34 (7.54%)
At close: Sep 18, 2025, 4:00 PM EDT
19.10
-0.01 (-0.05%)
After-hours: Sep 18, 2025, 7:59 PM EDT
Oscar Health Revenue
Oscar Health had revenue of $2.86B in the quarter ending June 30, 2025, with 29.04% growth. This brings the company's revenue in the last twelve months to $10.73B, up 48.29% year-over-year. In the year 2024, Oscar Health had annual revenue of $9.18B with 56.54% growth.
Revenue (ttm)
$10.73B
Revenue Growth
+48.29%
P/S Ratio
0.44
Revenue / Employee
$4,469,219
Employees
2,400
Market Cap
4.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.18B | 3.31B | 56.54% |
| Dec 31, 2023 | 5.86B | 1.90B | 47.92% |
| Dec 31, 2022 | 3.96B | 2.07B | 109.27% |
| Dec 31, 2021 | 1.89B | 1.50B | 384.43% |
| Dec 31, 2020 | 390.99M | -84.59M | -17.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
OSCR News
- 1 day ago - Oscar Health: The Market Is Mispricing This Disruptor - Seeking Alpha
- 2 days ago - What's Going On With Oscar Health Stock On Tuesday? - Benzinga
- 2 days ago - Oscar Health Prices Upsized $355,000,000 Convertible Senior Subordinated Notes Offering to Scale Long-Term Growth and Consumer and Employer Adoption of the Individual Market - Business Wire
- 3 days ago - Oscar Health Launches Proposed Convertible Senior Subordinated Notes Offering to Scale Long-Term Growth and Consumer and Employer Adoption of the Individual Market - Business Wire
- 13 days ago - Oscar Health: The Industry Is Having A Cold But 2026 Looks To Be Much Better - Seeking Alpha
- 24 days ago - Rocket, Oscar, Hims & Hers: Short Sellers Are Playing With Fire - Benzinga
- 4 weeks ago - What's Going On With Oscar Health Stock On Wednesday? - Benzinga
- 4 weeks ago - Oscar Health: Undervalued, But Not Without Risk - Seeking Alpha